These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17123439)

  • 21. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
    Patel P; White DL; Deswal A
    Am Heart J; 2007 Apr; 153(4):515-22. PubMed ID: 17383287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
    Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
    Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of heart failure by French general practitioners in 2003].
    Jondeau G; Allaert FA; Leurs I
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):833-9. PubMed ID: 15521474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription patterns in patients with systolic heart failure at hospital discharge: why beta blockers are underprescribed or prescribed at low dose in real life?
    Yilmaz MB; Refiker M; Guray Y; Guray U; Altay H; Demirkan B; Caldir V; Korkmaz S
    Int J Clin Pract; 2007 Feb; 61(2):225-30. PubMed ID: 17263710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC; Gheorghiade M; Abraham WT
    Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior.
    Chodoff P; Bischof RO; Nash DB; Laine C
    Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial.
    Majumdar SR; Tsuyuki RT; McAlister FA
    Am Heart J; 2007 Jan; 153(1):22.e1-8. PubMed ID: 17174632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community.
    Nielsen OW; McDonagh T; Cowburn P; Blue L; Robb SD; Dargie H
    Eur Heart J; 2004 Oct; 25(19):1718-25. PubMed ID: 15451150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART).
    Calvin JE; Shanbhag S; Avery E; Kane J; Richardson D; Powell L
    Congest Heart Fail; 2012; 18(2):73-8. PubMed ID: 22432552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey.
    Román-Sánchez P; Conthe P; García-Alegría J; Forteza-Rey J; Montero M; Montoto C
    QJM; 2005 Feb; 98(2):127-38. PubMed ID: 15655095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.
    Remme WJ; McMurray JJ; Hobbs FD; Cohen-Solal A; Lopez-Sendon J; Boccanelli A; Zannad F; Rauch B; Keukelaar K; Macarie C; Ruzyllo W; Cline C;
    Eur Heart J; 2008 Jul; 29(14):1739-52. PubMed ID: 18506054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription patterns of diuretics in chronic heart failure: a contemporary background as a clue to their role in treatment.
    Faggiano P; Opasich C; Tavazzi L; Achilli F; Gentile A; De Biase L; De Maria R; Pozzi R; Tarantini L; Gonzini L; Maggioni AP;
    J Card Fail; 2003 Jun; 9(3):210-8. PubMed ID: 12815571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V; Pääkkönen R; Hämäläinen H; Niemi M; Klaukka T
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.